F. Espósito

470 total citations
24 papers, 216 citations indexed

About

F. Espósito is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, F. Espósito has authored 24 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in F. Espósito's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Genomics and Diagnostics (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). F. Espósito is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Genomics and Diagnostics (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). F. Espósito collaborates with scholars based in Spain, Italy and United States. F. Espósito's co-authors include Joan Maurel, Leire Pedrosa, Timothy M. Thomson, Ana Ruiz‐Casado, Jorge Aparicio, P. Escudero, Ana Fernández Montés, E. Falcó, Carme Font and Claudio Zulli and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

F. Espósito

23 papers receiving 215 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Espósito Spain 8 95 44 38 32 32 24 216
Granada Perea Spain 8 74 0.8× 65 1.5× 91 2.4× 26 0.8× 37 1.2× 12 278
Waleed Sabry Canada 10 98 1.0× 93 2.1× 32 0.8× 16 0.5× 14 0.4× 23 266
Mandeep S. Dhami United States 3 302 3.2× 34 0.8× 26 0.7× 38 1.2× 39 1.2× 5 387
Yingping Cao China 9 129 1.4× 64 1.5× 17 0.4× 36 1.1× 33 1.0× 23 267
S. Chèze France 12 53 0.6× 39 0.9× 81 2.1× 27 0.8× 29 0.9× 22 421
Jodi V. Mones United States 8 90 0.9× 25 0.6× 25 0.7× 24 0.8× 41 1.3× 21 283
Mohamed Alsharedi United States 9 199 2.1× 59 1.3× 22 0.6× 65 2.0× 100 3.1× 33 336
Zhaojun Lu China 12 29 0.3× 83 1.9× 34 0.9× 71 2.2× 43 1.3× 27 304
Minodora Onisâi Romania 10 33 0.3× 31 0.7× 46 1.2× 44 1.4× 19 0.6× 40 266
Yasufumi Matsuda Japan 10 70 0.7× 93 2.1× 34 0.9× 33 1.0× 60 1.9× 27 259

Countries citing papers authored by F. Espósito

Since Specialization
Citations

This map shows the geographic impact of F. Espósito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Espósito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Espósito more than expected).

Fields of papers citing papers by F. Espósito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Espósito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Espósito. The network helps show where F. Espósito may publish in the future.

Co-authorship network of co-authors of F. Espósito

This figure shows the co-authorship network connecting the top 25 collaborators of F. Espósito. A scholar is included among the top collaborators of F. Espósito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Espósito. F. Espósito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Caiming, Alessandro Mannucci, F. Espósito, et al.. (2025). An Exosome-Based Liquid Biopsy Predicts Depth of Response and Survival Outcomes to Cetuximab and Panitumumab in Metastatic Colorectal Cancer: The EXONERATE Study. Clinical Cancer Research. 31(6). 1002–1015. 7 indexed citations
2.
Pedrosa, Leire, Isis K. Araujo, Míriam Cuatrecasas, et al.. (2023). Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology. Frontiers in Molecular Biosciences. 10. 1161893–1161893. 3 indexed citations
3.
4.
Font, Carme, Marta García de Herreros, Nikolaos Tsoukalas, et al.. (2022). Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies. Supportive Care in Cancer. 30(10). 8599–8609. 11 indexed citations
5.
Rodríguez, A., Laia Fernández‐Barat, F. Espósito, et al.. (2022). Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53–Mutated Metastatic Colorectal Cancer. Cancers. 14(23). 5921–5921. 3 indexed citations
6.
Cooksley, Tim, Shin Ahn, Nikolaos Tsoukalas, et al.. (2022). Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care. Supportive Care in Cancer. 30(10). 8577–8588. 10 indexed citations
7.
Herreros, Marta García de, F. Espósito, Tamara Saurí, & Carme Font. (2022). Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel. Journal of Oncology Pharmacy Practice. 29(3). 738–745.
8.
9.
Frère, Corinne, Carme Font, F. Espósito, et al.. (2021). Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis. Supportive Care in Cancer. 30(4). 2919–2931. 13 indexed citations
10.
11.
Conconi, Annarita, Annalisa Chiappella, Lorella Orsucci, et al.. (2021). INTENSIFIED (INTRAVENOUS AND INTRATHECAL) CNS PROPHYLAXIS IN PRIMARY TESTICULAR DIFFUSE LARGE B‐CELL LYMPHOMA: 5‐YEAR RESULTS OF THE IELSG30 TRIAL. Hematological Oncology. 39(S2). 14 indexed citations
12.
Victoria, Iván, Alberto Indacochea, Lydia Gaba, et al.. (2021). Genetic profiling across multiple cancer types using molecular prescreening comprehensive gene panels offered by clinical trials (CT).. Journal of Clinical Oncology. 39(15_suppl). 3060–3060. 1 indexed citations
13.
Rodríguez, A., Juan Moreno, F. Espósito, et al.. (2020). 476P Mutational profiling allows the stratification of metastatic colorectal cancer patients with poor prognosis. Annals of Oncology. 31. S443–S443. 1 indexed citations
14.
Pedrosa, Leire, Juan Moreno, F. Espósito, et al.. (2019). Immune signatures identify three immune clusters in mCRC, with potential clinical implications. Annals of Oncology. 30. iv120–iv120. 1 indexed citations
15.
Pedrosa, Leire, F. Espósito, Timothy M. Thomson, & Joan Maurel. (2019). The Tumor Microenvironment in Colorectal Cancer Therapy. Cancers. 11(8). 1172–1172. 59 indexed citations
16.
Lim, Chétana, Alexandre Doussot, Michael Osseis, et al.. (2018). Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first. Clinical & Translational Oncology. 20(10). 1274–1279. 6 indexed citations
17.
Landriscina, Matteo, Francesca Maddalena, Lorenza Sisinni, et al.. (2015). 2182 TRAP1 is a novel molecular target in BRAF-driven human colorectal carcinomas. European Journal of Cancer. 51. S394–S394. 1 indexed citations
18.
Manci, Natalina, Cláudia Marchetti, Chiara Di Tucci, et al.. (2011). A prospective phase II study of topotecan (Hycamtin®) and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. Gynecologic Oncology. 122(2). 285–290. 12 indexed citations
19.
Impellizzeri, Franco M., et al.. (2005). The use of heart rate reserve to monitor soccer-specific exercises. 58(2). 97–105. 1 indexed citations
20.
Espósito, F., et al.. (1994). Clinical and tomographic findings in vascular dementia. Aging Clinical and Experimental Research. 6(1). 57–64. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Granada Perea Breakdown of academic impact, for papers by Waleed Sabry Breakdown of academic impact, for papers by Mandeep S. Dhami Breakdown of academic impact, for papers by Yingping Cao Breakdown of academic impact, for papers by S. Chèze Breakdown of academic impact, for papers by Jodi V. Mones Breakdown of academic impact, for papers by Mohamed Alsharedi Breakdown of academic impact, for papers by Zhaojun Lu Breakdown of academic impact, for papers by Minodora Onisâi Breakdown of academic impact, for papers by Yasufumi Matsuda
Rankless by CCL
2026